List of insiders holdings for Radius Health Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Rubric Capital Management LP Rosen David Efraim 10% Owner |
2022-08-12 12:06:22 | 0 8,642,271 |
8,642,271 | Form 4 |
| 2 | EVNIN LUKE Former 10% stockholder |
2016-09-29 18:05:35 | 0 5,831,253 |
5,831,253 | Form 4 |
| 3 | Nordic Bioscience Clinical Development VII A/S 10% Owner |
2014-01-06 15:51:06 | 5,025,540 0 |
5,025,540 | Form 13D |
| 4 | GALAKATOS NICHOLAS SIMON NICHOLAS J III WHEELER KURT Former 10% stockholder |
2016-09-29 18:04:35 | 0 3,689,706 |
3,689,706 | Form 4 |
| 5 | Fromkin Andrew J. President & CEO |
2013-11-18 13:51:29 | 2,427,133 0 |
2,427,133 | Form 4 |
| 6 | MPM BioVentures IV LLC MPM BioVentures IV GP LLC MPM Bio IV NVS Strategic Fund LP DOMBKOWSKI ASHLEY L Greene William KAILIAN VAUGHN M Scopa James Paul St Peter Steven Vander Vort John 10% Owner |
2011-05-19 11:58:56 | 0 2,382,430 |
2,382,430 | Form 3 |
| 7 | MPM BioVentures IV LLC Scopa James Paul MPM BioVentures IV GP LLC MPM Bio IV NVS Strategic Fund LP KAILIAN VAUGHN M Foley Todd Former 10% stockholder |
2016-09-29 18:03:16 | 0 2,141,547 |
2,141,547 | Form 4 |
| 8 | BROOKSIDE CAPITAL MANAGEMENT LLC BROOKSIDE CAPITAL INVESTORS L P BROOKSIDE CAPITAL PARTNERS FUND LP 10% Owner |
2017-02-14 10:09:40 | 1,643,001 0 |
1,643,001 | Form 13G |
| 9 | WYZGA MICHAEL S Chief Executive Officer |
2012-06-22 11:42:57 | 1,530,000 0 |
1,530,000 | Form 4 |
| 10 | HEALTHCARE VENTURES VII LP HealthCare Partners VII L.P. CAVANAUGH JAMES H LAWLOR AUGUSTINE LITTLECHILD JOHN W Mirabelli Christopher WERNER HAROLD R 10% Owner |
2015-01-28 18:45:57 | 1,367,780 0 |
1,367,780 | Form 13D |
| 11 | BRENNER LOUIS MD Chief Medical Officer |
2012-09-28 10:30:41 | 1,192,100 0 |
1,192,100 | Form 4 |
| 12 | WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 10% Owner |
2015-02-25 17:15:59 | 1,000,000 0 |
1,000,000 | Form 13G |
| 13 | Lyttle Cecil Richard President & C.E.O. |
2013-12-06 17:10:49 | 66,666 767,174 |
833,840 | Form 3 |
| 14 | Healthcare Private Equity Limited Partnership 10% Owner |
2013-05-09 14:04:36 | 816,462 0 |
816,462 | Form 13D |
| 15 | Ward Rob President & CEO |
2015-10-23 21:45:39 | 781,605 0 |
781,605 | Form 4 |
| 16 | F2 Bioscience III L.P. F2 Bioscience GP Ltd. F2 Capital Ltd Priestley Katherine Globeways Holdings Ltd 10% Owner |
2015-01-20 21:17:19 | 360,091 0 |
360,091 | Form 13D |
| 17 | F2 Bioscience IV L.P. F2 Bioscience IV GP Ltd. F2 Capital Ltd Priestley Katherine F2 Bio Ventures V L.P. F2 Bio Ventures GP Ltd. Globeways Holdings Ltd 10% Owner |
2015-01-20 21:17:34 | 360,091 0 |
360,091 | Form 13D |
| 18 | F2 Bioscience IV L.P. F2 Bioscience IV GP Ltd. F2 Capital Ltd Priestley Katherine F2 Bio Ventures V L.P. F2 Bio Ventures GP Ltd. Globeways Holdings Ltd F2 Bioscience VI L.P. 10% Owner |
2015-01-20 21:17:34 | 360,091 0 |
360,091 | Form 13D |
| 19 | Yates John Chief Medical Officer |
2014-02-19 16:53:39 | 300,000 0 |
300,000 | Form 4 |
| 20 | Jovan-Embiricos Morana Director 10% Owner |
2015-01-20 16:17:20 | 0 267,786 |
267,786 | Form 4/A |
| 21 | O'Dea Louis Sr. VP, Chief Medical Officer |
2011-11-08 21:56:08 | 262,636 0 |
262,636 | Form 4 |
| 22 | MPM BioVentures IV LLC Scopa James Paul Vander Vort John MPM BioVentures IV GP LLC MPM Bio IV NVS Strategic Fund LP Foley Todd KAILIAN VAUGHN M 10% Owner |
2013-04-30 13:55:09 | 0 250,733 |
250,733 | Form 4 |
| 23 | Ward Robert President & CEO |
2017-02-22 16:31:06 | 187,800 0 |
187,800 | Form 4 |
| 24 | Durand Mark Chief Commercial Officer |
2014-06-09 20:41:34 | 175,438 0 |
175,438 | Form 4 |
| 25 | Ipsen Pharma SAS Ipsen S.A. 10% Owner |
2011-06-23 11:19:27 | 173,260 0 |
173,260 | Form 13D |
| 26 | MPM BioVentures IV LLC MPM BioVentures IV GP LLC MPM Bio IV NVS Strategic Fund LP Foley Todd KAILIAN VAUGHN M Scopa James Paul St Peter Steven Vander Vort John 10% Owner |
2011-12-16 17:23:06 | 0 114,537 |
114,537 | Form 4 |
| 27 | Hoeiland Jesper President and CEO |
2020-02-24 17:56:20 | 107,000 0 |
107,000 | Form 4 |
| 28 | MPM BIOVENTURES III LLC HENNER DENNIS MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC MPM BIOVENTURES III GMBH & CO. Beteiligungs KG MPM BIOVENTURES III PARALLEL FUND L.P. MPM BIOVENTURES III GP L.P. MPM BIOVENTURES III L.P. MPM BIOVENTURES III-QP L.P. STEINMETZ MICHAEL Former 10% stockholder |
2018-08-30 16:06:05 | 100,000 0 |
100,000 | Form 13D |
| 29 | Harvey Brian Nicholas Sr. VP and CFO |
2017-04-27 20:58:58 | 76,189 0 |
76,189 | Form 4 |
| 30 | Hatzis-Schoch Brent Sr. VP, General Counsel |
2019-02-26 18:14:33 | 72,944 0 |
72,944 | Form 4 |
| 31 | Franken Michael Sr. Vice President and CBO |
2012-06-19 14:14:35 | 70,000 0 |
70,000 | Form 4 |
| 32 | Williams Gregory C. Chief Development Officer |
2018-02-15 19:49:55 | 60,000 0 |
60,000 | Form 4 |
| 33 | HARRIS ALAN G Chief Medical Officer |
2014-12-19 17:04:05 | 50,000 0 |
50,000 | Form 4 |
| 34 | Conley Mark William VP, Chief Financial Officer |
2022-03-17 16:35:21 | 50,000 0 |
50,000 | Form 4 |
| 35 | FLEMING JONATHAN Director |
2011-12-16 17:08:45 | 0 49,127 |
49,127 | Form 4 |
| 36 | Carmona Jose Chief Financial Officer |
2020-02-28 16:15:13 | 46,708 0 |
46,708 | Form 4 |
| 37 | Purandare Dinesh SVP, Head of Global Oncology |
2017-02-22 16:28:53 | 35,000 0 |
35,000 | Form 4 |
| 38 | Morris Charles Q Chief Medical Officer |
2020-02-28 16:15:18 | 33,744 0 |
33,744 | Form 4 |
| 39 | Helwig Steven Principal Financial Officer |
2022-01-25 16:30:51 | 31,251 0 |
31,251 | Form 4 |
| 40 | Stoner Elizabeth Director |
2014-12-19 17:03:05 | 30,000 0 |
30,000 | Form 4 |
| 41 | Hopfield Jessica Director |
2020-02-24 17:57:23 | 28,300 0 |
28,300 | Form 4 |
| 42 | GADICKE ANSBERT Director |
2017-02-22 16:25:25 | 27,500 0 |
27,500 | Form 4 |
| 43 | AUERBACH ALAN H Director |
2017-02-22 16:22:08 | 27,500 0 |
27,500 | Form 4 |
| 44 | Kelly Joseph Francis Sr. VP of Sales and Marketing |
2020-02-28 16:15:21 | 24,111 0 |
24,111 | Form 4 |
| 45 | Graves Kurt Director |
2020-02-24 17:54:59 | 21,000 0 |
21,000 | Form 4 |
| 46 | Muenchbach Martin Director |
2015-05-26 19:14:52 | 15,000 0 |
15,000 | Form 4 |
| 47 | Rosenberg Anthony Director |
2020-02-28 16:15:17 | 12,401 0 |
12,401 | Form 4 |
| 48 | Dolan Dan VP of Finance |
2020-11-10 18:32:20 | 12,000 0 |
12,000 | Form 4 |
| 49 | Grausso Sal Chief Commercial Officer |
2021-02-26 16:36:59 | 11,709 0 |
11,709 | Form 4 |
| 50 | Chopas James George Principal Finance Accounting |
2021-03-09 06:54:29 | 6,701 0 |
6,701 | Form 4 |
| 51 | Snow David P. Chief Commercial Officer |
2018-02-06 17:13:54 | 6,448 0 |
6,448 | Form 5 |
| 52 | Roychowdhury Debasish Director |
2019-04-12 16:14:11 | 5,500 0 |
5,500 | Form 4 |
| 53 | Hattersley Gary Chief Scientific Officer |
2019-02-13 17:33:00 | 1,173 0 |
1,173 | Form 5 |
| 54 | Fitzpatrick Lorraine A. Chief Medical Officer |
2019-02-13 17:30:48 | 989 0 |
989 | Form 5 |
| 55 | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
2022-08-30 17:02:52 | 0 0 |
0 | Form 13D |
| 56 | BIOTECH GROWTH N V BB BIOTECH AG 10% Owner |
2022-08-30 17:02:52 | 0 0 |
0 | Form 13D |
| 57 | Lisa Susan Vissers Director |
2022-08-15 16:20:10 | 0 0 |
0 | Form 4 |
| 58 | Hughes Owen Director |
2022-08-15 16:19:43 | 0 0 |
0 | Form 4 |
| 59 | SANDERS MACHELLE Director |
2022-08-15 16:19:46 | 0 0 |
0 | Form 4 |
| 60 | Shah Chhaya Chief Business Officer |
2022-08-15 16:19:20 | 0 0 |
0 | Form 4 |
| 61 | FRIEDMAN CATHY Director |
2022-08-15 16:17:09 | 0 0 |
0 | Form 4 |
| 62 | Dere Willard H Director |
2022-08-15 16:16:39 | 0 0 |
0 | Form 4 |
| 63 | Jarrett Jennifer Director |
2022-08-15 16:16:10 | 0 0 |
0 | Form 4 |
| 64 | GARNIER JEAN PIERRE Director |
2022-08-15 16:16:10 | 0 0 |
0 | Form 4 |
| 65 | VON ESCHENBACH ANDREW C. Director |
2022-08-15 16:15:16 | 0 0 |
0 | Form 4 |
| 66 | Holtschlag Danielle Vice President, Sales |
2022-08-15 16:14:43 | 0 0 |
0 | Form 4 |
| 67 | Messersmith Elizabeth Senior Vice President |
2022-08-15 16:14:07 | 0 0 |
0 | Form 4 |
| 68 | Martin G. Kelly CEO and President |
2022-08-15 16:13:34 | 0 0 |
0 | Form 4 |
| 69 | Murphy Sean Director |
2022-08-15 16:14:07 | 0 0 |
0 | Form 4 |